Detalhe da pesquisa
1.
SIRT1 as a potential biomarker of response to treatment with glatiramer acetate in multiple sclerosis.
Exp Mol Pathol
; 102(2): 191-197, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28109694
2.
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis.
Exp Mol Pathol
; 99(3): 498-505, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26407760
3.
Epigenetic modifications induced by RGC-32 in colon cancer.
Exp Mol Pathol
; 88(1): 67-76, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19883641